Photo via Al Jazeera

Could one daily pill narrow the diabetes treatment gap in the Global South?

Read the original at Al Jazeera ↗
Cite

Chughtai, A. (2026, November 14). Could one daily pill narrow the diabetes treatment gap in the Global South? Al Jazeera. https://www.aljazeera.com/news/2026/11/14/could-one-daily-pill-narrow-the-diabetes-treatment-gap-in-the-global-south?traffic_source=rss

Dated from the outlet's own feed. Check the original for its byline.

Al Jazeera · collected 2026-11-14 · by Alia Chughtai

Quick Summary

The article discusses the shift from weekly GLP-1 injections to once-daily oral pills for diabetes treatment, which could significantly improve accessibility, especially in the Global South where diabetes rates are high. Countries like Pakistan, with a 31.4% diabetes prevalence, face high costs for GLP-1 injections, such as Mounjaro, priced at 220,000 rupees ($723) for imported versions. In contrast, locally manufactured oral semaglutide is about $18 for a month's supply, making it much more affordable. This shift could bridge the treatment gap and reduce reliance on cold-chain storage, a significant barrier in many developing countries.
Written by AI on 2026-11-16, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

The shift from injectable diabetes medications to daily pills could significantly change how diabetes is treated, especially in the Global South. Medications like Ozempic and Mounjaro, which are currently administered as weekly injections, are moving towards daily pill formats, potentially making treatment more accessible. This change could also benefit patients managing obesity, as these drugs have shown effectiveness in weight management and associated health issues like heart and kidney problems, liver disease, and osteoarthritis. However, the accessibility of these new oral medications remains a concern, as the shift could affect who can afford and receive the treatment.

Written for “Daily Pill for Diabetes Treatment” on 2026-11-17, grounded in this article and the 0 other(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.

Story

Daily Pill for Diabetes Treatment
Health · 1 article(s) covering the same event.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
72
sentences that state something as happening or true
Uncertain
14%
10 of 72 hedged ("reportedly", "may", "according to")
Leaning
Leans left
of the writing, not the subject · beta estimate
Publisher signals
60/100
Al Jazeera's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-16 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Al Jazeera · 5928 article(s) · 4 correction(s) detected
Running correction rate · 4 correction(s)

Who wrote this

Alia Chughtai
10 article(s) here · 1 carrying a prediction
Medication that has been a lifeline for patients with uncontrollable diabetes is now slowly shifting from injections to pills, a move that could fundamentally alter treatment for the disease – and who can access it.
Voters will choose all 435 members of the US House of Representatives and 35 of the Senate’s 100 seats.
“We barely live day-to-day, waiting to see how the next day will pass,” she said.
On November 3, about 210 million registered voters will decide how much power Donald Trump has for the rest of his US presidency.
2026-10-26 · assertive framing · US midterm elections 2026 in maps and charts
At Karachi Zoo, Jude Allen sang, You Are My Sunshine, to an elephant he could not save.
That includes people who are seeking asylum in the US, who are supposed to be given a chance to explain dangers they might face in their home country.
The mission demonstrated that humans could survive launch, weightlessness and re-entry, giving the Soviet Union a major early victory in the Cold War Space Race. Six years later, on October 10, 1967, the Outer Space Treaty entered into force.
Even before the latest fighting, more than 2.2 million children under five were projected to be acutely malnourished this year, more than half a million of them with severe acute malnutrition, the deadliest form, UNICEF’s Louise Wateridge told Al Jazeera.
She works long hours in an affluent neighbourhood, has a husband who can no longer work due to health issues and she has three children in middle and high school. Jibran says her rent has gone up from 15,000 Pakistani rupees ($54) at the end of last year to 25,000 rupees ( 90) this past month. “Before the war, everyone could eat and drink.
- list 2 of 4Iran bets economic pain will pressure Trump in game of ‘chicken’ - list 3 of 4Iran, Oman agree on new temporary route in Hormuz - list 4 of 4Trump threatens Iran’s partners: How do secondary sanctions work?
Also by Alia Chughtai
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 10 articles by Alia Chughtai →

Topics

Kuwait Mounjaro Ozempic Pakistan Saudi Arabia

Subjects

Pakistan GPE · 5× Alavi PERSON · 2× Kuwait GPE · 2× Saudi Arabia GPE · 2× Eli Lily’s ORG · 1× FDA ORG · 1× Gaza GPE · 1× Sudan GPE · 1× healthcare ORG · 1× the United States GPE · 1×

Narrative

They not only help type 2 diabetes patients manage their weight, but can also help non-diabetics tackle obesity, improving cardiac and renal outcomes, liver disease, obstructive sleep apnea and osteoarthritis. “They can be used for management of all these things when weight reduction is important, or sugar control is important, or both,” he said.
framing: assertive · carried by 1 article(s) · first seen 2026-11-16
Medication that has been a lifeline for patients with uncontrollable diabetes is now slowly shifting from injections to pills, a move that could fundamentally alter treatment for the disease – and who can access it.

Claims (72 extracted, 10 hedged)

Medication that has been a lifeline for patients with uncontrollable diabetes is now slowly shifting from injections to pills, a move that could fundamentally alter treatment for the disease – and who can access it. uncertain
who → shift → it
This shift could also affect the treatment of obesity, a long misunderstood condition once associated with overeating and laziness, rather than the metabolic disorder it is now recognised as. uncertain
it → affect → overeating
Recommended Stories list of 4 items- list 1 of 4Can GLP-1 drugs like Ozempic cause vision loss? asserted
drugs → cause → loss
What we know about the risk - list 2 of 4Sweet scoop: asserted
know → know → risk
4With every rainfall, Gaza risks losing access to power and healthcare GLP-1 (glucagon-like peptide-1) receptor agonists therapy isn’t new. asserted
therapy → risk → power
The first FDA-approved drug, Exenatide, hit the market in 2005 and was followed by Liraglutide in 2009, which was seen as a revolutionary alternative to insulin. asserted
which → approve → insulin
But the market has until recently been dominated by weekly injections like Ozempic and Wegovy (semaglutide), and Mounjaro (tirzepatide). asserted
market → dominate → Ozempic
These drugs have also proved successful for weight loss. asserted
drugs → prove → loss
Now, once-daily oral GLP pills are emerging as an alternative, especially for the diabetes-stricken Global South. asserted
pills → emerge → South
Oral once-daily pills of the same wonder drug could make access more affordable, and less reliant on the cold chain that GLP-1 injections and insulin depend on – and that are harder to secure in emerging economies. uncertain
that → make → economies
Why this matters asserted
this → matter → ?
One in nine people in the world between the ages of 20-79 lives with diabetes, and one in eight people globally is obese. asserted
people → live → diabetes
The GLP injections come with a high price tag and are often not covered by insurance companies, which treat them as an elective drug. asserted
which → come → drug
In the United States, Eli Lily’s Mounjaro costs about $500 for a month’s worth of doses; in the UK, about 199 pounds ($264); and in Saudi Arabia, 1,261 riyals ($336). asserted
Mounjaro → cost → Arabia
In India, the brand is locally manufactured and available at 14,766 rupees ($157). asserted
brand → manufacture → rupees
In Pakistan, the imported Mounjaro is a whopping 220,000 rupees ($723), while the locally manufactured Tirzepatide from Getz Pharma costs 17,000 rupees ($61). asserted
Tirzepatide → import → rupees
While pills are usually taken once a day, injections are once per week. asserted
injections → take → week
Pakistan has the highest diabetes prevalence in the world – 31.4 percent of its population suffer from the disease – followed by the Marshall Islands (25.7 percent) and Kuwait (25.6 percent). asserted
percent → have → Islands
Many other Middle Eastern countries rank among nations with the highest diabetes prevalence. asserted
countries → rank → prevalence
For many countries in the Global South, the relative affordability of oral GLP drugs, where the locally manufactured oral semaglutide is about $18 for a 30-day supply, could make them more accessible for diabetes and obesity patients, remove the need for refrigeration and make rural distribution easier. Dr Zakir Alavi is an endocrinologist in Karachi, Pakistan and has been treating patients with diabetes and obesity for nearly 30 years. uncertain
Alavi → manufacture → years
We have, on one hand, childhood malnutrition, underweight, and stunted growth. asserted
We → have → malnutrition
On the other hand, we have childhood and adult obesity,” said Alavi. asserted
Alavi → have → obesity
“And surprisingly, there is at least some element in the adult and childhood obesity which can be linked to a malnourished mother, and an underweight, premature baby.” asserted
which → be → mother
Malnutrition during pregnancy can lead to low birth weight, and babies born small who gain weight rapidly in infancy face a higher risk of childhood obesity, according to doctors. uncertain
who → lead → doctors
Alavi said GLP drugs – whether the injectables or pills – have revolutionised the management of type 2 diabetes and obesity. asserted
drugs → say → diabetes
They not only help type 2 diabetes patients manage their weight, but can also help non-diabetics tackle obesity, improving cardiac and renal outcomes, liver disease, obstructive sleep apnea and osteoarthritis. “They can be used for management of all these things when weight reduction is important, or sugar control is important, or both,” he said. asserted
he → help → things
Malik has been at the front line of helping patients with diabetes and obesity, and he echoed Alavi’s views. asserted
he → help → views
“We looked at how much weight you need to lose to cure diabetes, the magic number seemed to come in at around 15kg, at least,” he said, speaking of research on the subject. asserted
he → look → subject
How was GLP therapy discovered? asserted
therapy → discover → ?
Jens Juul Holst is one of the central scientists behind the GLP revolution that has given millions around the world a way to live with diabetes and, for those struggling with obesity, a chance to reclaim their bodies. asserted
that → give → bodies
A professor, physician and physiologist, Holst lives in Copenhagen and began his journey with gut hormones in the 1970s. asserted
Holst → live → 1970s
“When we discovered this, what we found was an insulin-releasing peptide from the gut,” Holst told Al Jazeera. asserted
Holst → discover → Jazeera
“We were interested in what regulates insulin secretion, and that was as a physiological mechanism because we had some people who were developing too low blood glucose levels, [which is called] hypoglycemia, and we were looking for a peptide that could create insulin release stimulation and then be responsible for the low glucose levels.” uncertain
that → regulate → levels
He says reactive hypoglycemia, which patients experience after certain operations like bariatric surgery, explains how the GLP molecule works. asserted
molecule → say → surgery
Eventually, his team discovered that the molecule plays a role not only in insulin release and secretion, but also helps regulate appetite and food intake. asserted
molecule → discover → appetite
“The discovery of that was actually perhaps even more exciting than the discovery of its insulin-releasing activities,” Holst said, the excitement in his voice rising. asserted
excitement → release → voice
“And then, the big day really was when we were able to infuse people with diabetes with this new peptide and see what happened.” asserted
what → infuse → peptide
They found that an intravenous infusion of GLP-1 “would normalise blood glucose levels completely in people with long-standing, problematic type 2 diabetes and this happened in the course of four hours,” he said. asserted
he → find → hours
“From then on, we knew that we were really onto something big.” asserted
we → know → something
Holst and his team’s discovery led to what is now known as semaglutide, which paved the way for another drug, tirzepatide, and a third drug called retatrutide that is currently undergoing trials with a potential release in 2027. asserted
that → lead → 2027
…and 32 more, not listed.
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support